Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
Status:
Terminated
Trial end date:
2017-03-07
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies whether the levels of certain genes in the tissue and blood
are related to how well patients with stage IV non-small cell lung cancer respond to
chemotherapy. Genes may affect how sensitive or resistant tumors are to chemotherapy.
Studying the levels of genes related to tumor response before and after chemotherapy may help
doctors learn whether they can predict how well patients will respond to treatment.